Đang chuẩn bị liên kết để tải về tài liệu:
Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computeraided phage display methodologies

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Claudin-low breast carcinoma represents 19% of all breast cancer cases and is characterized by an aggressive progression with metastatic nature and high rates of relapse. Due to a lack of known specific molecular biomarkers for this breast cancer subtype, there are no targeted therapies available, which results in the worst prognosis of all breast cancer subtypes. |